AU2013257482A1 - Methods and compositions for administration of oxybutynin - Google Patents

Methods and compositions for administration of oxybutynin

Info

Publication number
AU2013257482A1
AU2013257482A1 AU2013257482A AU2013257482A AU2013257482A1 AU 2013257482 A1 AU2013257482 A1 AU 2013257482A1 AU 2013257482 A AU2013257482 A AU 2013257482A AU 2013257482 A AU2013257482 A AU 2013257482A AU 2013257482 A1 AU2013257482 A1 AU 2013257482A1
Authority
AU
Australia
Prior art keywords
oxybutynin
administration
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013257482A
Other versions
AU2013257482B2 (en
Inventor
Michael J. Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microdose Therapeutx Inc
Original Assignee
Microdose Therapeutx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008259864A external-priority patent/AU2008259864C1/en
Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc
Priority to AU2013257482A priority Critical patent/AU2013257482B2/en
Publication of AU2013257482A1 publication Critical patent/AU2013257482A1/en
Application granted granted Critical
Publication of AU2013257482B2 publication Critical patent/AU2013257482B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013257482A 2007-05-30 2013-11-14 Methods and compositions for administration of oxybutynin Ceased AU2013257482B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013257482A AU2013257482B2 (en) 2007-05-30 2013-11-14 Methods and compositions for administration of oxybutynin

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US94090707P 2007-05-30 2007-05-30
US60/940,907 2007-05-30
AU2008259864A AU2008259864C1 (en) 2007-05-30 2008-05-30 Methods and compositions for administration of Oxybutynin
AU2013257482A AU2013257482B2 (en) 2007-05-30 2013-11-14 Methods and compositions for administration of oxybutynin

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2008259864A Division AU2008259864C1 (en) 2007-05-30 2008-05-30 Methods and compositions for administration of Oxybutynin

Publications (2)

Publication Number Publication Date
AU2013257482A1 true AU2013257482A1 (en) 2013-12-05
AU2013257482B2 AU2013257482B2 (en) 2016-07-14

Family

ID=40088519

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2008259864A Ceased AU2008259864C1 (en) 2007-05-30 2008-05-30 Methods and compositions for administration of Oxybutynin
AU2013257482A Ceased AU2013257482B2 (en) 2007-05-30 2013-11-14 Methods and compositions for administration of oxybutynin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2008259864A Ceased AU2008259864C1 (en) 2007-05-30 2008-05-30 Methods and compositions for administration of Oxybutynin

Country Status (7)

Country Link
US (1) US20080299207A1 (en)
EP (1) EP2152232A4 (en)
KR (2) KR20100021451A (en)
AU (2) AU2008259864C1 (en)
BR (1) BRPI0812000A2 (en)
CA (2) CA2859004A1 (en)
WO (1) WO2008151092A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
AU2004203700B2 (en) * 2003-01-02 2007-06-21 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US20080153789A1 (en) * 2006-12-26 2008-06-26 Femmepharma Holding Company, Inc. Topical administration of danazol
US9119777B2 (en) * 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
EP2772252B1 (en) * 2011-10-26 2020-03-18 Hisamitsu Pharmaceutical Co., Inc. Oxybutynin-containing transdermal absorption preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736577A (en) * 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US6026809A (en) * 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
JP2003500354A (en) * 1999-05-20 2003-01-07 セプラコール， インク． Method for treating asthma using S-oxybutynin
US8820316B2 (en) * 2000-02-11 2014-09-02 Respironics Respiratory Drug Delivery (Uk) Ltd Drug delivery apparatus
BR0206300A (en) * 2001-11-05 2008-04-08 Upjohn Co pharmaceutical composition to treat urinary disorder in a mammal and use
CA2498189A1 (en) * 2002-10-29 2004-05-13 Pharmacia & Upjohn Company Llc Quaternary ammonium compounds
DE602004003172T2 (en) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham METHOD FOR THE TREATMENT OF DISEASES OF THE LOWER HARN PATHS WITH ANTIMIC CARCINICS AND WITH MODULATORS OF THE ALPHA-2-DELTA SUB-UNIT OF THE CALCIUM CHANNEL
DE602004007225T2 (en) * 2003-04-04 2008-03-06 Dynogen Pharmaceuticals Inc., Waltham METHOD FOR THE TREATMENT OF LOWER HARN PATTERNS
CA2585122A1 (en) * 2004-10-25 2006-05-04 Schering Corporation M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders

Similar Documents

Publication Publication Date Title
EP2331072B8 (en) Methods and compositions for oral administration of proteins
EP2315780B8 (en) Compositions and methods of use for therapeutic antibodies
EP2475632A4 (en) Monochlorotrifluoropropene compounds and compositions and methods using same
EP3284772B8 (en) Thioethers, methods for their preparation, and compositions including such thioethers
EP2370434B8 (en) Isoquinolinyl-containing alkaloid compounds and compositions useful for reducing lipid levels
EP2483362A4 (en) Fluoropropene compounds and compositions and methods using same
AU2013257482A1 (en) Methods and compositions for administration of oxybutynin
IL200141A0 (en) Compositions and methods of use of phorbol esters
EP2403505B8 (en) Therapeutic uses of mastic gum fractions
EP2152232A4 (en) Methods and compositions for administration of oxybutynin
IL213177A0 (en) Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide
IL209698A (en) Use of nifurtimox for the preparation of pharmaceuticals and compositions comprising said nifurtimox
WO2010011622A9 (en) Ophthalmic gallium compositions and methods of their use
AU2007906531A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
AU2008906219A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
WO2009120815A9 (en) Therapeutic compositions and methods
AU2007906771A0 (en) Nutraceutical composition and methods of use
AU2007906770A0 (en) Nutraceutical composition and methods of use
AU2014200650C1 (en) Anti-CXCR1 compositions and methods
AU2006906669A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
AU2007901739A0 (en) Methods and compositions for treatment of menorrhagia
AU2009267729B2 (en) Methods and compositions for enhanced delivery of macromolecules
AU2014233629B2 (en) Orally administered corticosteroid compositions
AU2008905185A0 (en) Methods and compositions for preparing hormone-depleted surem
AU2009905930A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions